Skip to content

Clinical trials

Withdrawn Phase 2 Carcinoma, Hepatocellular trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 2 Status: Withdrawn Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20071
20081
20091
20101
20111
20121
20131
20143
20152
20163
20171
20185
20194
20203
20212
20223
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University6
Case Comprehensive Cancer Center2
M.D. Anderson Cancer Center2
National Cancer Institute (NCI)2
OHSU Knight Cancer Institute2
Shanghai Zhongshan Hospital2
Shi Ming2
Washington University School of Medicine2
Zhejiang University2
A2 Healthcare Taiwan Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular42
Liver Neoplasms5
Bile Duct Neoplasms1
Carcinoma1
Cholangiocarcinoma1
Fibrosis1
Gallbladder Neoplasms1
Hepatitis B, Chronic1
Liver Cirrhosis1
Liver Failure1

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.